# FDA recall D-0764-2023

> **Sagent Pharmaceuticals Inc** · Class II · drug recall initiated 2023-05-19.

## Product

Nafcillin for Injection, USP, 10 gram per Pharmacy Bulk Package, Rx only, Mfd. for SAGENT Pharmaceuticals, Schaumburg, IL 60195.  NDC:  25021-141-99

## Reason for recall

Lack of Assurance of Sterility

## Distribution

Nationwide USA

## Key facts

- **Recall number:** D-0764-2023
- **Recalling firm:** Sagent Pharmaceuticals Inc
- **Classification:** Class II
- **Product type:** drug
- **Status:** Ongoing
- **Initiation date:** 2023-05-19
- **Report date:** 2023-05-31

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Schaumburg, IL, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0764-2023

## Citation

> AI Analytics. FDA recall D-0764-2023. Retrieved 2026-06-24 from https://api.ai-analytics.org/recall/D-0764-2023. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*